INSMED INCORPORATED
Last · NASDAQ$97.79+1.00 (+1.03%)close · yahoo · 17h ago
Market cap$21.36B218.4M sh
P/E · TTM-23.9fwd 130 · eps -4.10 · loss
Beta0.82vs S&P 500
Div yield0.00%annual · TTM
52w range
$90.39$212.75
Volume2.7Msession
| Revenue | $606.4M |
|---|---|
| Operating income | $-1.2B |
| Net income | $-1.3B |
| Free cash flow | $-967.6M |
| Operating margin | -205.6% |
| Net margin | -210.5% |
| Return on equity | -172.8% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-19
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 25.2%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -210.5%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -154.2%
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 763%
- Rd Intensity High — R&D/Revenue 127.2%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.38
Est. revenue
497.5M
Earnings transcripts
Documents
FormReporting forFiledFlags